Processa Pharmaceuticals, Inc. (PCSA) stock
PCSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$1.70−0.03 (-1.73%)
Close on Nov 18, 2026Market cap $4.75MP/E –Yield –
Processa Pharmaceuticals price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Processa Pharmaceuticals's price to sales ratio was 273.8× on Jan 31, 2017.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2017 | Jan 31, 2017 | 273.8× | −179.5 |
| 2016 | Dec 30, 2016 | 453.3× | −41.0 |
| 2015 | Nov 30, 2015 | 494.3× | – |
See a number that looks wrong?